Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunter Schuch

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survivalSonja Loges, Gerhard Heil, Melanie Bruweleit, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)Eckart Laack, Antje Scheffler, Iris Burkholder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Michael Görn, Manuela Anige, Iris Burkholder, et al.
Anticancer Research|April 1, 2009
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastasesIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasisSonja Loges, Henning Clausen, Uta Reichelt, et al.
Stem Cells and Development|June 23, 2005
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitorsGeorg Bartsch, James J Yoo, Paolo De Coppi, et al.
Onkologie|December 7, 2005
Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot studyEckart Laack, Birte Andritzky, Heinz Dürk, et al.
Onkologie|April 18, 2008
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)Michael Görn, Christian R Habermann, Manuela Anige, et al.
Journal of Neuroimmunology|May 23, 2006
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cellsDjordje Atanackovic, Benjamin Schnee, Gunter Schuch, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survivalSonja Loges, Gerhard Heil, Melanie Bruweleit, et al.
Lung Cancer (Amsterdam, Netherlands)|July 5, 2005
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC)Eckart Laack, Antje Scheffler, Iris Burkholder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Lung Cancer (Amsterdam, Netherlands)|June 14, 2005
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC)Michael Görn, Manuela Anige, Iris Burkholder, et al.
Anticancer Research|April 1, 2009
Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastasesIna Thöm, Olaf Schult-Kronefeld, Iris Burkholder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasisSonja Loges, Henning Clausen, Uta Reichelt, et al.
Stem Cells and Development|June 23, 2005
Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitorsGeorg Bartsch, James J Yoo, Paolo De Coppi, et al.
Onkologie|December 7, 2005
Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot studyEckart Laack, Birte Andritzky, Heinz Dürk, et al.
Onkologie|April 18, 2008
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC)Michael Görn, Christian R Habermann, Manuela Anige, et al.
Journal of Neuroimmunology|May 23, 2006
Acute psychological stress alerts the adaptive immune response: stress-induced mobilization of effector T cellsDjordje Atanackovic, Benjamin Schnee, Gunter Schuch, et al.
Pageof 5